| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.18 | 0.4 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |